Cargando…

High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy

Immunotherapy based on natural killer (NK) cell infusions is a potential adjuvant treatment for many cancers. Such therapeutic application in humans requires large numbers of functional NK cells that have been selected and expanded using clinical grade protocols. We established an extremely efficien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spanholtz, Jan, Tordoir, Marleen, Eissens, Diana, Preijers, Frank, van der Meer, Arnold, Joosten, Irma, Schaap, Nicolaas, de Witte, Theo M., Dolstra, Harry
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821405/ https://www.ncbi.nlm.nih.gov/pubmed/20169160 http://dx.doi.org/10.1371/journal.pone.0009221

Ejemplares similares

Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
por: Spanholtz, Jan, et al.
Publicado: (2011)

Defining Early Human NK Cell Developmental Stages in Primary and Secondary Lymphoid Tissues
por: Eissens, Diana N., et al.
Publicado: (2012)

Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rg(null) Mice
por: Cany, Jeannette, et al.
Publicado: (2013)

Extensive natural killer cell receptor phenotyping on NK and T cells discloses differences in RA and PsA, potentially mirroring diverse immunoregulatory functions
por: van Bijnen, Sandra TA, et al.
Publicado: (2011)

Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
por: Shah, Nina, et al.
Publicado: (2013)

IL-12 Directs Further Maturation of Ex Vivo Differentiated NK Cells with Improved Therapeutic Potential
por: Lehmann, Dorit, et al.
Publicado: (2014)

siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice
por: van der Waart, Anniek B., et al.
Publicado: (2015)

Clinical Grade Treg: GMP Isolation, Improvement of Purity by CD127(pos) Depletion, Treg Expansion, and Treg Cryopreservation
por: Peters, Jorieke H., et al.
Publicado: (2008)

Good manufacturing practice production of CD34(+) progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia
por: de Jonge, P. K. J. D., et al.
Publicado: (2023)

Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy
por: GRANZIN, MARKUS, et al.
Publicado: (2015)

Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8(+) T cells
por: Mousset, Charlotte M., et al.
Publicado: (2020)

A trispecific killer engager molecule against CLEC12A effectively induces NK cell mediated killing of AML cells
por: Arvindam, Upasana Sunil, et al.
Publicado: (2020)

Genetic Engineering of Natural Killer Cells for Enhanced Antitumor Function
por: Mantesso, Simone, et al.
Publicado: (2020)

Cytokine-based high log-scale expansion of functional human dendritic cells from cord-blood CD34-positive cells
por: Harada, Yui, et al.
Publicado: (2011)

Variability in the Log Domain and Limitations to Its Approximation by the Normal Distribution
por: Elassaiss‐Schaap, Jeroen, et al.
Publicado: (2020)

Concurrent Detection of Circulating Minor Histocompatibility Antigen-Specific CD8(+) T Cells in SCT Recipients by Combinatorial Encoding MHC Multimers
por: Broen, Kelly, et al.
Publicado: (2011)

Effect of expansion of human umbilical cord blood CD34 + cells on neurotrophic and angiogenic factor expression and function
por: Watt, Ashalyn P., et al.
Publicado: (2022)

Human Cytomegalovirus Infection Increases Both Antibody- and Non–Antibody-Dependent Cellular Reactivity by Natural Killer Cells
por: Michelo, Clive M., et al.
Publicado: (2017)

Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer Therapy
por: Seay, Howard R., et al.
Publicado: (2016)

Cytokine-Based Log-Scale Expansion of Functional Murine Dendritic Cells
por: Harada, Yui, et al.
Publicado: (2009)

Evaluation of Expansion and Maintenance of Umbilical Cord Blood CD34(+) Cells in The Co-Culture with Umbilical Cord Blood-Derived Mesenchymal Stem Cells in The Presence of Microcarrier Beads
por: Naseri Mobaraki, Sepideh, et al.
Publicado: (2023)

Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8(+) T cells for adoptive immunotherapy
por: Mousset, Charlotte M., et al.
Publicado: (2018)

Logging and log management: the authoritative guide to understanding the concepts surrounding logging and log management
por: Chuvakin, Anton, et al.
Publicado: (2013)

Human serum albumin promotes self-renewal and expansion of umbilical cord blood CD34(+) hematopoietic stem/progenitor cells
por: Hua, Jing, et al.
Publicado: (2023)

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer
por: Veluchamy, John Pradeep, et al.
Publicado: (2016)

CH02 peptide promotes ex vivo expansion of umbilical cord blood-derived CD34 (+) hematopoietic stem/progenitor cells : CH02 peptide promotes CD34 (+) UCB-HSPC ex vivo expansion
por: Yang, Yiqi, et al.
Publicado: (2023)

Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma
por: Kisseberth, William C., et al.
Publicado: (2021)

Natural killer cells in antitumour adoptive cell immunotherapy
por: Laskowski, Tamara J., et al.
Publicado: (2022)

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic Strategies
por: Chouaib, Salem, et al.
Publicado: (2014)

Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma
por: van Vliet, Amanda A., et al.
Publicado: (2021)

CD34(+) progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg(null) mice
por: Van der Meer, Jolien M.R., et al.
Publicado: (2021)

Intraperitoneal infusion of ex vivo-cultured allogeneic NK cells in recurrent ovarian carcinoma patients (a phase I study)
por: Hoogstad-van Evert, Janneke, et al.
Publicado: (2019)

Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells
por: Kim, Ji Sung, et al.
Publicado: (2015)

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
por: Lupo, Kyle B., et al.
Publicado: (2019)

Logging in Java with the JDK 1.4 Logging API and Apache log4j
por: Gupta, Samudra
Publicado: (2005)

CD34(+) stem cells from umbilical cord blood
por: Pafumi, Carlo, et al.
Publicado: (2011)

Umbilical cord blood CD34(+) progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rg(null) mice
por: Hoogstad-van Evert, Janneke S., et al.
Publicado: (2017)

Expansion of NKG2C-expressing Natural Killer Cells after Umbilical Cord Blood Transplantation in a Patient with Peripheral T-cell Lymphoma with Cytotoxic Molecules
por: Muta, Tsuyoshi, et al.
Publicado: (2017)

Differential ability of MSCs isolated from placenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34(+) cells
por: Kadekar, Darshana, et al.
Publicado: (2015)

Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
por: Lamers-Kok, Nina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aufgpa1cpmrol97gotb14tp5ba